Export 2730 results:
Author [ Title(Desc)] Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
A. Krishnan, Pasquini, M. C., Logan, B., Stadtmauer, E. A., Vesole, D. H., Alyea, E., Antin, J. H., Comenzo, R., Goodman, S., Hari, P., Laport, G., Qazilbash, M. H., Rowley, S., Sahebi, F., Somlo, G., Vogl, D. T., Weisdorf, D., Ewell, M., Wu, J., Geller, N. L., Horowitz, M. M., Giralt, S., and Maloney, D. G., “Autologous haemopoietic stem-cell transplantation followed by allogeneic or autologous haemopoietic stem-cell transplantation in patients with multiple myeloma (BMT CTN 0102): a phase 3 biological assignment trial.”, Lancet Oncol, vol. 12, no. 13, pp. 1195-203, 2011.
J. C. Alvarnas, Le Rademacher, J., Wang, Y., Little, R. F., Akpek, G., Ayala, E., Devine, S., Baiocchi, R., Lozanski, G., Kaplan, L., Noy, A., Popat, U., Hsu, J., Morris, L. E., Thompson, J., Horowitz, M. M., Mendizabal, A., Levine, A., Krishnan, A., Forman, S. J., Navarro, W. H., and Ambinder, R., “Autologous hematopoietic cell transplantation for HIV-related lymphoma: results of the BMT CTN 0803/AMC 071 trial.”, Blood, vol. 128, no. 8, pp. 1050-8, 2016.
V. Karantalis, DiFede, D., Gerstenblith, G., Pham, S., Symes, J., Zambrano, J., Fishman, J., Pattany, P., McNiece, I., Conte, J., ,, Mendizabal, A., Karas, T., Byrnes, J., Lowery, M., Heldman, A., and J, H., “Autologous Mesenchymal Stem Cells Produce Concordant Improvements in Regional Function, Tissue Perfusion, and Fibrotic Burden When Administered to Patients Undergoing Coronary Artery Bypass Grafting [..]”, Circ Res, vol. 114, pp. 1302-1310, 2014.
V. Karantalis, DiFede, D. L., Gerstenblith, G., Pham, S., Symes, J., Zambrano, J. Pablo, Fishman, J., Pattany, P., McNiece, I., Conte, J., Schulman, S., Wu, K., Shah, A., Breton, E., Davis-Sproul, J., Schwarz, R., Feigenbaum, G., Mushtaq, M., Suncion, V. Y., Lardo, A. C., Borrello, I., Mendizabal, A., Karas, T. Z., Byrnes, J., Lowery, M., Heldman, A. W., and Hare, J. M., “Autologous mesenchymal stem cells produce concordant improvements in regional function, tissue perfusion, and fibrotic burden when administered to patients undergoing coronary artery bypass grafting: The Prospective Randomized Study of Mesenchymal Stem Ce”, Circ Res, vol. 114, no. 8, pp. 1302-10, 2014.
E. A. Stadtmauer, Pasquini, M. C., Blackwell, B., Hari, P., Bashey, A., Devine, S., Efebera, Y., Ganguly, S., Gasparetto, C., Geller, N., Horowitz, M. M., Koreth, J., Knust, K., Landau, H., Brunstein, C., McCarthy, P., Nelson, C., Qazilbash, M. H., Shah, N., Vesole, D. H., Vij, R., Vogl, D. T., Giralt, S., Somlo, G., and Krishnan, A., “Autologous Transplantation, Consolidation, and Maintenance Therapy in Multiple Myeloma: Results of the BMT CTN 0702 Trial.”, J Clin Oncol, vol. 37, no. 7, pp. 589-597, 2019.
M. R. Tomblyn, Ewell, M., Bredeson, C., Kahl, B. S., Goodman, S. A., Horowitz, M. M., Vose, J. M., Negrin, R. S., and Laport, G. G., “Autologous versus reduced-intensity allogeneic hematopoietic cell transplantation for patients with chemosensitive follicular non-Hodgkin lymphoma beyond first complete response or first partial response.”, Biol Blood Marrow Transplant, vol. 17, no. 7, pp. 1051-7, 2011.
M. Tomblyn, Ewell, M., Bredeson, C., Kahl, B., Goodman, S., Horowitz, M., Vose, J., Negrin, R., and Laport, G., “Autologous vs. Reduced Intensity Allogeneic Hematopoietic Cell Transplantation for Patients with Chemosensitive Follicular Non-Hodgkin's Lymphoma Beyond First Complete Response or First Partial Response”, Biol Blood Marrow Transplant, vol. 17, pp. 1051-1057, 2011.
G. Laport, Bredeson, C., Tomblyn, M. R., Kahl, B. S., Goodman, S. A., Ewell, M., Klein, J., Horowitz, M. M., Vose, J. M., and Negrin, R. S., “Autologous vs. Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation for Patients with Follicular Non-Hodgkins Lymphoma (FL) Beyond First Complete Response or First Partial Response”, in American Society of Clinical Oncology Annual Meeting, Chicago, IL, 2008.
M. J. Mulligan, Bernstein, D. I., Winokur, P., Rupp, R., Lai, L., Anderson, E., Rouphael, N., Dickey, M., Stapleton, J. T., Edupuganti, S., Spearman, P., Kabbani, S., Ince, D., Noah, D. L., Hill, H., and Bellamy, A. R., “Avian Influenza A/H7N9 Vaccine Mixed with MF59 Adjuvant at the Point-of-Use. A Randomized Clinical Trial of a Pandemic Threat Response.”, in ID Week 2014, Philadelphia, PA, 2014.
B
and , “Background Morbidity in HIV Vaccine Trial Participants From Various Geographic Regions as Assessed by Unsolicited Adverse Events”, Hum Vaccin Immunother, vol. 8, pp. 630-638, 2012.
C. Schmidt, Smith, C., Barin, B., Bakhtyari, A., Bart, P. - A., Bekker, L. - G., Chomba, E., Clumeck, N., Ho, D., Hoosen, A., Jaoko, W., Kaleebu, P., Karita, E., Keefer, M. C., van Lunzen, J., McMichael, A., Mehendale, S., Peters, B., Ramanathan, V. D., Robinson, A., Rockstroh, J., Vardas, E., Vets, E., Weber, J., Graham, B. S., Than, S., Excler, J. - L., Kochhar, S., Ho, M., Heald, A., and Fast, P. E., “Background morbidity in HIV vaccine trial participants from various geographic regions as assessed by unsolicited adverse events.”, Hum Vaccin Immunother, vol. 8, no. 5, pp. 630-8, 2012.
L. C. Racusen, Solez, K., Colvin, R. B., Bonsib, S. M., Castro, M. C. R., Cavallo, T., Croker, B. P., Demetris, A. J., Drachenberg, C. B., Fogo, A. B., Furness, P., Gaber, L. W., Gibson, I. W., Glotz, D. G., Goldberg, J. C., Grande, J., Halloran, P. F., Hansen, H. E., Hartley, B., Hayry, P. J., and Hill, C. Mand, “The Banff 97 working classification of renal allograft pathology”, Kidney Int., vol. 55, pp. 713-23, 1999.
L. C. Racusen, Solez, K., Colvin, R. B., Bonsib, S. M., Castro, M. C., Cavallo, T., Croker, B. P., Demetris, A. J., Drachenberg, C. B., Fogo, A. B., Furness, P., Gaber, L. W., Gibson, I. W., Glotz, D., Goldberg, J. C., Grande, J., Halloran, P. F., Hansen, H. E., Hartley, B., Hayry, P. J., Hill, C. M., Hoffman, E. O., Hunsicker, L. G., Lindblad, A. S., and Yamaguchi, Y., “The Banff 97 working classification of renal allograft pathology.”, Kidney Int, vol. 55, no. 2, pp. 713-23, 1999.
C. R. Wolfe, Tomashek, K. M., Patterson, T. F., Gomez, C. A., Marconi, V. C., Jain, M. K., Yang, O. O., Paules, C. I., Palacios, G. M. Ruiz, Grossberg, R., Harkins, M. S., Mularski, R. A., Erdmann, N., Sandkovsky, U., Almasri, E., Pineda, J. Regalado, Dretler, A. W., de Castilla, D. Lopez, Branche, A. R., Park, P. K., Mehta, A. K., Short, W. R., McLellan, S. L. F., Kline, S., Iovine, N. M., Sahly, H. M. El, Doernberg, S. B., Oh, M. - D., Huprikar, N., Hohmann, E., Kelley, C. F., Holodniy, M., Kim, E. Suk, Sweeney, D. A., Finberg, R. W., Grimes, K. A., Maves, R. C., Ko, E. R., Engemann, J. J., Taylor, B. S., Ponce, P. O., Larson, L. A., Melendez, D. Paolo, Seibert, A. M., Rouphael, N. G., Strebe, J., Clark, J. L., Julian, K. G., de Leon, A. Ponce, Cardoso, A., de Bono, S., Atmar, R. L., Ganesan, A., Ferreira, J. L., Green, M., Makowski, M., Bonnett, T., Beresnev, T., Ghazaryan, V., Dempsey, W., Nayak, S. U., Dodd, L. E., Beigel, J. H., and Kalil, A. C., “Baricitinib versus Dexamethasone for Adults Hospitalised with COVID-19 (ACTT-4): a Randomised, Double-blind, Double Placebo-controlled Trial”, Lancet Respir Med, vol. 10, no. 9, pp. 888-899, 2022.
I. U. Scott, Oden, N. L., VanVeldhuisen, P. C., Ip, M. S., and Blodi, B. A., “Baseline Characteristics and Outcomes After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema in Participants with Hemiretinal Vein Occlusion Compared With Participants with Central Retinal Vein Occlusion (SCORE2) Report 18”, JAMA Ophthalmol, vol. 140, no. 5, pp. 458-464, 2022.
T. E. Clemons, Gillies, M. C., Chew, E. Y., Bird, A. C., Peto, T., Figueroa, M. J., Harrington, M. W., and Group, T. Macular Te, “Baseline Characteristics of Participants in the Natural History Study of Macular Telangiectasia (MacTel) MacTel Project Report No. 2”, Ophthalmic Epidemiol, vol. 17, pp. 66-73, 2010.
T. E. Clemons, Gillies, M. C., Chew, E. Y., Bird, A. C., Peto, T., Figueroa, M. J., and Harrington, M. W., “Baseline characteristics of participants in the natural history study of macular telangiectasia (MacTel) MacTel Project Report No. 2.”, Ophthalmic Epidemiol, vol. 17, no. 1, pp. 66-73, 2010.
I. U. Scott, VanVeldhuisen, P. C., Ip, M. S., Blodi, B. A., Oden, N. L., King, J., Antoszyk, A. N., Peters, M. A., and Tolentino, M., “Baseline Factors Associated With 6-Month Visual Acuity and Retinal Thickness Outcomes in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Study Report 4.”, JAMA Ophthalmol, vol. 135, no. 6, pp. 639-649, 2017.
L. Lai, Rouphael, N., Xu, Y., Sherman, A. C., Edupuganti, S., Anderson, E. J., Lankford-Turner, P., Wang, D., Keitel, W., McNeal, M. M., Cross, K., Hill, H., Bellamy, A. R., and Mulligan, M. J., “Baseline Levels of Influenza-Specific B Cells and T Cell Responses Modulate Human Immune Responses to Swine Variant Influenza A/H3N2 Vaccine.”, Vaccines (Basel), vol. 8, no. 1, 2020.
W. Stevens, Kamali, A., Karita, E., Anzala, O., Sanders, E. J., Jaoko, W., Kaleebu, P., Mulenga, J., Dally, L., Fast, P., Gilmour, J., Farah, B., Birungi, J., Hughes, P., Manigart, O., Stevens, G., Yates, S., Thomson, H., ,, Stoll-Johnson, L., and Ketter, N., “Baseline Morbidity in 2,990 Adult African Volunteers Recruited to Characterize Laboratory Reference Intervals for Future HIV Vaccine Clinical Trials”, PLoS ONE, vol. 3, p. e2043, 2008.
W. Stevens, Kamali, A., Karita, E., Anzala, O., Sanders, E. J., Jaoko, W., Kaleebu, P., Mulenga, J., Dally, L., Fast, P., Gilmour, J., Farah, B., Birungi, J., Hughes, P., Manigart, O., Stevens, G., Yates, S., Thomson, H., von Lieven, A., Krebs, M., Price, M. A., Stoll-Johnson, L., and Ketter, N., “Baseline morbidity in 2,990 adult African volunteers recruited to characterize laboratory reference intervals for future HIV vaccine clinical trials.”, PLoS One, vol. 3, no. 4, p. e2043, 2008.
A. D. Meleth, SanGiovanni, J. P., Chew, E. Y., Gensler, G., and Clemons, T. E., “Baseline Nutritional Characteristics of the Age-Related Eye Disease Study 2 (AREDS2) Cohort”, in Annual Meeting, Association for Research in Vision and Ophthalmology (ARVO), Fort Lauderdale, FL, 2009.
A. - R. Eye Diseas Group, “Baseline nutritional status of AREDS participants, Poster presentation by AREDS participants”, Experimental Biology, 1999.
L. P. Aiello, Vignati, L., Sheetz, M. J., Zhi, X., Girach, A., Davis, M. D., Milton, R. C., and Group, T. P. K. C. D. R. S. 2 S., “Baseline Patient Characteristics in the PKC-DRS2 Trial: The Effect of The PKC-b Inhibitor Ruboxistaurin on Moderate Visual Loss”, in 13th Congress of the European Society of Ophthalmology (SOE) and the 103rd Congress of German Society of Ophthalmology (DOG), Berlin, Germany, 2005.
I. Scott, Van Veldhuisen, P., Oden, N., Ip, M., Blodi, B., Hartnett, M., Cohen, G., and Group, S. C. O. R. E. Study Inve, “Baseline Predictors of Visual Acuity and Retinal Thickness Outcomes in Patients with Retinal Vein Occlusion. SCORE Study Report 10”, Ophthalmology, vol. 118, pp. 345-352, 2011.